JYOTHYLAB - Investment Analysis: Buy Signal or Bull Trap?
Back to ListInvestment Rating: 4.4
| Stock Code | JYOTHYLAB | Market Cap | 7,658 Cr. | Current Price | 209 ₹ | High / Low | 400 ₹ |
| Stock P/E | 22.2 | Book Value | 39.2 ₹ | Dividend Yield | 1.68 % | ROCE | 37.1 % |
| ROE | 29.0 % | Face Value | 1.00 ₹ | DMA 50 | 246 ₹ | DMA 200 | 296 ₹ |
| Chg in FII Hold | 0.66 % | Chg in DII Hold | -0.94 % | PAT Qtr | 81.1 Cr. | PAT Prev Qtr | 87.8 Cr. |
| RSI | 24.9 | MACD | -10.9 | Volume | 14,50,734 | Avg Vol 1Wk | 9,96,819 |
| Low price | 206 ₹ | High price | 400 ₹ | PEG Ratio | 0.57 | Debt to equity | 0.04 |
| 52w Index | 1.24 % | Qtr Profit Var | -7.20 % | EPS | 9.33 ₹ | Industry PE | 27.5 |
📊 Analysis: Jyothy Labs (JYOTHYLAB) demonstrates strong fundamentals with ROCE at 37.1% and ROE at 29%, reflecting excellent capital efficiency. The PEG ratio of 0.57 suggests undervaluation relative to growth, while a healthy dividend yield of 1.68% adds to long-term attractiveness. Debt-to-equity is very low at 0.04, ensuring financial stability. However, weak technicals (RSI 24.9, MACD -10.9) indicate bearish momentum in the short term.
💰 Entry Zone: Ideal accumulation range is ₹200–₹215, close to the support zone near ₹206, offering margin of safety against the 52-week high of ₹400.
📈 Exit / Holding Strategy: For existing holders, maintain positions for 3–5 years given strong ROCE/ROE and low debt. Consider partial profit booking near ₹360–₹380 if valuations stretch, while retaining core holdings for dividend yield and compounding potential.
Positive
- High ROCE (37.1%) and ROE (29%) indicate strong operational efficiency.
- PEG ratio of 0.57 highlights undervaluation relative to growth.
- Healthy dividend yield of 1.68% supports long-term investors.
- Low debt-to-equity (0.04) ensures financial resilience.
Limitation
- Quarterly profit decline (-7.2%) raises concerns about earnings consistency.
- Weak RSI (24.9) and negative MACD (-10.9) show bearish technical momentum.
- Stock trading below DMA 50 (₹246) and DMA 200 (₹296), indicating downtrend.
- DII holding reduced (-0.94%), showing cautious domestic sentiment.
Company Negative News
- Sequential PAT decline from ₹87.8 Cr. to ₹81.1 Cr. reflects short-term pressure.
- Domestic institutional investors reduced stake (-0.94%).
Company Positive News
- FII holding increased (+0.66%), signaling foreign investor confidence.
- Strong fundamentals with consistent dividend payouts.
Industry
- Industry P/E at 27.5, slightly higher than JYOTHYLAB’s P/E of 22.2, suggesting relative undervaluation.
- Consumer goods sector remains resilient with steady demand, though competition is intense.
Conclusion
✅ Jyothy Labs is a fundamentally strong candidate for long-term investment, supported by high ROCE/ROE, low debt, and attractive PEG ratio. Ideal entry is near ₹200–₹215 for margin of safety. Long-term investors should hold for 3–5 years, with partial exits near ₹360–₹380 to balance valuation risks while compounding core holdings.
Would you like me to prepare a peer benchmarking overlay comparing Jyothy Labs with other FMCG players (like Dabur, Marico, and Emami) on ROE, ROCE, PEG, and dividend yield, so you can see how it stacks up against competitors?